Biomica Announces Agreement with Sheba Medical Center for Joint Microbiome Clinical Research
The research will be focused on developing new treatments for Inflammatory Bowel Disease (IBD) REHOVOT, Israel, April 13, 2022 /PRNewswire/ — Biomica Ltd. (Biomica), an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd….
Comments Off on Biomica Announces Agreement with Sheba Medical Center for Joint Microbiome Clinical Research